Literature DB >> 5413292

Acid metabolites of monoamines in avian brain; effects of probenecid and reserpine.

L Ahtee, D F Sharman, M Vogt.   

Abstract

1. The concentration of the dopamine (DA) metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in the anterior part of the nucleus basalis of pigeon brain was found to be 0.17 +/- 0.01 mug/g, which is about one-fifth of the concentration of homovanillic acid (HVA) in this region. In the chicken, the concentration of HVA in the (entire) nucleus basalis was 0.06 +/- 0.006 mug/g, lower than in any other species examined, and giving a ratio of DA to HVA of about 50. The concentration of DOPAC in the 8 day old chick was 0.053 +/- 0.002 mug/g.2. Probenecid, 200 mg/kg intramuscularly, doubled the content of DOPAC in the nucleus basalis of the pigeon and increased the concentration of HVA in both the pigeon and the chicken by a factor of 4 to 5. These findings demonstrate the existence, in avian brain, of an active transport mechanism for the removal of acidic substances and explain the low concentrations of the acids found in bird brain.3. A method is described for the estimation of 5-hydroxytryptamine (5-HT) and 5-hydroxyindolylacetic acid (5-HIAA) in the same tissue sample. Probenecid caused an increase in the 5-HIAA content but produced no change in the 5-HT content of the nucleus basalis of pigeon brain.4. Reserpine caused a fall in the content of acidic DA metabolites in the nucleus basalis of the pigeon. The effect was more pronounced after raising the concentration of these acids with probenecid.5. Treatment of pigeons with pargyline (100 mg/kg 17 hr before decapitation) did not significantly increase the DA content of the nucleus basalis, but it prevented to some extent the loss in DA caused by reserpine.6. Pigeons and chickens were sedated by probenecid. The deepest sedation occurred at about the same time as the greatest increase in the acidic amine metabolites in the brain.7. Intracisternal injection of HVA in the pigeon and intravenous injection of large amounts of HVA, DOPAC, 5-HIAA or 3,4-dimethoxyphenylacetic acid into newly hatched chicks did not produce any sedation or other effects on behaviour. In contrast, injection of sodium gamma-hydroxybutyrate caused paralysis followed by prostration and eye closure.8. Estimation of the concentration of HVA in the brain of the young chick after intravenous injection of the acid (100 mg/kg) showed that the concentration was of the same order of magnitude as it is in animals given probenecid; this suggests that the sedation which follows probenecid is not related to the accumulation of acidic amine metabolites.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5413292      PMCID: PMC1702636          DOI: 10.1111/j.1476-5381.1970.tb10337.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

2.  THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  Effect of probenecid on the level of homovanillic acid in the corpus striatum.

Authors:  B Werdinius
Journal:  J Pharm Pharmacol       Date:  1966-08       Impact factor: 3.765

4.  Brain amine content and functional maturity in the fowl: the effects of pargyline.

Authors:  J S Watts; H C Mendez; J F Reilly; S Krop
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-03

5.  Discussion of factors modulating brain serotonin turnover.

Authors:  B Werdinius
Journal:  Adv Pharmacol       Date:  1968

6.  Monoamines and their metabolites in the avian brain.

Authors:  A V Juorio; M Vogt
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

7.  Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1966-11

8.  The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse.

Authors:  G F Murphy; D Robinson; D F Sharman
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

9.  A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1967-08
  9 in total
  21 in total

1.  On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.

Authors:  N Awazi; H C Guldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  Effects of tetrahydropapaveroline and salsolinol on cerebral monoamine metabolism and their interactions with psychopharmacological drugs.

Authors:  N Awazi; H C Guldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

3.  5-hydroxytryptamine in platelets and brain of rabbits treated chronically with imipramine, morphine or methadone.

Authors:  L Ahtee; I Kääriäinen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Further evidence for negative feedback control of serotonin release in the central nervous system.

Authors:  P A Baumann; P C Waldmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

5.  Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.

Authors:  A G Roberge; L J Poirier
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

6.  Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.

Authors:  K Kiianmaa; L M Attila
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

7.  Production of catalepsy and depletion of brain monoamines by a butyrophenone derivative.

Authors:  L D Fuenmayor; M Vogt
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

8.  Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride).

Authors:  R B Holman; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

9.  Influence of age and of testosterone on the response of male rats to parachlorophenylalanine.

Authors:  V J Bond; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

10.  The effect of parachlorophenylalanine on the behaviour of cats.

Authors:  V J Hoyland; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1970-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.